probenecid has been researched along with Acrodermatitis in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Acrodermatitis: Inflammation involving the skin of the extremities, especially the hands and feet. Several forms are known, some idiopathic and some hereditary. The infantile form is called Gianotti-Crosti syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The role of an anion carrier was investigated by treating normal human fibroblasts, and those carrying a mutation which affects zinc transport, acrodermatitis enteropathica (AE), with the anion carrier inhibitor, probenecid." | 3.70 | Zinc uptake into fibroblasts is inhibited by probenecid. ( Chang, CY; Grider, A; Muga, SJ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CY | 1 |
| Muga, SJ | 1 |
| Grider, A | 1 |
1 other study available for probenecid and Acrodermatitis
| Article | Year |
|---|---|
Zinc uptake into fibroblasts is inhibited by probenecid.
Topics: Acrodermatitis; Cells, Cultured; Dose-Response Relationship, Drug; Endocytosis; Fibroblasts; Humans; | 1998 |